Frequency of all Adverse Events 6 years [clinicaltrials_resource:7e1a9d27c3655ab566ef77e44a1e28da]
750mg Intravenous, monthly and individual dosing schedule
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Frequency of all Adverse Events 6 years [clinicaltrials_resource:7e1a9d27c3655ab566ef77e44a1e28da]
750mg Intravenous, monthly and individual dosing schedule
Bio2RDF identifier
7e1a9d27c3655ab566ef77e44a1e28da
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7e1a9d27c3655ab566ef77e44a1e28da
measure [clinicaltrials_vocabulary:measure]
Frequency of all Adverse Events
time frame [clinicaltrials_vocabulary:time-frame]
description
750mg Intravenous, monthly and individual dosing schedule
identifier
clinicaltrials_resource:7e1a9d27c3655ab566ef77e44a1e28da
title
Frequency of all Adverse Events 6 years
@en
type
label
Frequency of all Adverse Event ...... a9d27c3655ab566ef77e44a1e28da]
@en